DNA methylation changes associated with risk factors in tumors of the upper aerodigestive tract

Epigenetics

Volumn 7, Issue 3, 2012, Pages 270-277

  Mani, Samson ^a   Szymańska, Katarzyna ^a   Cuenin, Cyrille ^a   Zaridze, David ^b   Balassiano, Karen ^a   Lima, Sheila C S ^a,i   Matos, Elena ^c   Daudt, Alexander ^d   Koifman, Sergio ^e   Filho, Victor Wunsch ^f   Menezes, Ana M B ^g   Curado, Maria Paula ^h   Ferro, Gilles ^a   Vaissière, Thomas ^a   Sylla, Bakary S ^a   Tommasino, Massimo ^a   Pinto, Luis Felipe Ribeiro ^i,j   Boffetta, Paolo ^h,k   Hainaut, Pierre ^a   Brennan, Paul ^a   Herceg, Zdenko ^a   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

^g FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^h INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

ⁱ INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^j STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^k MOUNT SINAI SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Biomarkers; Cancer; DNA methylation; Risk factors; Upper aerodigestive tract

Indexed keywords

CHRNA3 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; MTHFR PROTEIN; MYOD1 PROTEIN; NICOTINIC RECEPTOR; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DNA DETERMINATION; DNA METHYLATION; EPIGENETICS; FEMALE; GENE IDENTIFICATION; GENETIC ASSOCIATION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ANALYSIS; SEX DIFFERENCE; SMOKING; UPPER AERODIGESTIVE TRACT CANCER;

HUMAN PAPILLOMAVIRUS; NICOTIANA TABACUM;

EID: 84858235579     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.7.3.19306     Document Type: Article

References (43)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Clin 2005; 55:74-108;PMID:15761078; http://dx.doi.org/10.3322/canjclin.55.2.74.
2. Boyle P, Macfarlane GJ, Zheng T, Maisonneuve P, Evstifeeva T, Scully C. Recent advances in epidemiology of head and neck cancer. Curr Opin Oncol 1992; 4:471-7;PMID:1498155; http://dx.doi.org/10.1097/00001622-199206000-00008.
3. Lippman SM, Hong WK. Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys 1989; 17:691-4;PMID:2674081; http://dx.doi.org/10.1016/0360-3016(89)90126-0.
4. Hashibe M, McKay JD, Curado MP, Oliveira JC, Koifman S, Koifman R, et al. Multiple ADH genes are associated with upper aerodigestive cancers. Nat Genet 2008; 40:707-9;PMID:18500343; http://dx.doi.org/10.1038/ng.151.
5. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128:683-92;PMID:17320506; http://dx.doi.org/10.1016/j.cell.2007.01.029.
6. Kraunz KS, Hsiung D, McClean MD, Liu M, Osanyingbemi J, Nelson HH, et al. Dietary folate is associated with p16(INK4A) methylation in head and neck squamous cell carcinoma. Int J Cancer 2006; 119:1553-7;PMID:16646054; http://dx.doi.org/10.1002/ijc.22013.
7. Marsit CJ, McClean MD, Furniss CS, Kelsey KT. Epigenetic inactivation of the SFRP genes is associated with drinking, smoking and HPV in head and neck squamous cell carcinoma. Int J Cancer 2006; 119:1761-6;PMID:16708382; http://dx.doi.org/10.1002/ijc.22051.
8. Smith IM, Mydlarz WK, Mithani SK, Califano JA. DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage. Int J Cancer 2007; 121:1724-8;PMID:17582607; http://dx.doi.org/10.1002/ijc.22889.
9. Puri SK, Si L, Fan CY, Hanna E. Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma. Am J Otolaryngol 2005; 26:12-7;PMID:15635575; http://dx.doi.org/10.1016/j.amjoto.2004.06.007.
10. Maruya S, Issa JP, Weber RS, Rosenthal DI, Haviland JC, Lotan R, et al. Differential methylation status of tumor-associated genes in head and neck squamous carcinoma: incidence and potential implications. Clin Cancer Res 2004; 10:3825-30;PMID:15173091; http://dx.doi.org/10.1158/1078-0432.CCR-03-0370.
11. Hasegawa M, Nelson HH, Peters E, Ringstrom E, Posner M, Kelsey KT. Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Oncogene 2002; 21:4231-6;PMID:12082610; http://dx.doi.org/10.1038/sj.onc.1205528.
12. Sinčić N, Herceg Z. DNA methylation and cancer: ghosts and angels above the genes. Curr Opin Oncol 2011; 23:69-76;PMID:21119515; http://dx.doi.org/10.1097/CCO.0b013e3283412eb4.
13. Rodríguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med 2011; 17:330-9;PMID:21386836; http://dx.doi.org/10.1038/nm.2305.
14. Ghosh A, Ghosh S, Maiti GP, Sabbir MG, Zabarovsky ER, Roy A, et al. Frequent alterations of the candidate genes hMLH1, ITGA9 and RBSP3 in early dysplastic lesions of head and neck: clinical and prognostic significance. Cancer Sci 2010; 101:1511-20;PMID:20412120; http://dx.doi.org/10.1111/j.1349-7006.2010.01551.x.
15. Smith IM, Mithani SK, Mydlarz WK, Chang SS, Califano JA. Inactivation of the tumor suppressor genes causing the hereditary syndromes predisposing to head and neck cancer via promoter hypermethylation in sporadic head and neck cancers. ORL J Otorhinolaryngol Relat Spec 2010; 72:44-50;PMID:20332657; http://dx.doi.org/10.1159/000292104.
16. Steinmann K, Sandner A, Schagdarsurengin U, Dammann RH. Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma. Oncol Rep 2009; 22:1519-26;PMID:19885608.
17. Marsit CJ, Christensen BC, Houseman EA, Karagas MR, Wrensch MR, Yeh RF, et al. Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma. Carcinogenesis 2009; 30:416-22;PMID:19126652; http://dx.doi.org/10.1093/carcin/bgp006.
18. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 2004; 83:1-1438;PMID:15285078.
19. Pöschl G, Seitz HK. Alcohol and cancer. Alcohol Alcohol 2004; 39:155-65;PMID:15082451; http://dx.doi.org/10.1093/alcalc/agh057.
20. Dai M, Clifford GM, le Calvez F, Castellsagué X, Snijders PJ, Pawlita M, et al.; IARC Multicenter Oral Cancer Study Group. Human papillomavirus type 16 and Tp53 mutation in oral cancer: matched analysis of the IARC multicenter study. Cancer Res 2004; 64:468-71;PMID:14744758; http://dx.doi.org/10.1158/0008-5472.CAN-03-3284.
21. Goldenberg D, Golz A, Joachims HZ. The beverage maté: a risk factor for cancer of the head and neck. Head Neck 2003; 25:595-601;PMID:12808663; http://dx.doi.org/10.1002/hed.10288.
22. Szymańska K, Matos E, Hung RJ, Wünsch-Filho V, Eluf-Neto J, Menezes A, et al. Drinking of maté and the risk of cancers of the upper aerodigestive tract in Latin America: a case-control study. Cancer Causes Control 2010; 21:1799-806;PMID:20623173; http://dx.doi.org/10.1007/s10552-010-9606-6.
23. Saulnier A, Vaissière T, Yue J, Siouda M, Malfroy M, Accardi R, et al. Inactivation of the putative suppressor gene DOK1 by promoter hypermethylation in primary human cancers. Int J Cancer 2011;PMID:21796618; http://dx.doi.org/10.1002/ijc.26299.
24. Eads CA, Lord RV, Wickramasinghe K, Long TI, Kurumboor SK, Bernstein L, et al. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res 2001; 61:3410-8;PMID:11309301.
25. Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008; 452:633-7;PMID:18385738; http://dx.doi.org/10.1038/nature06885.
26. Paliwal A, Vaissière T, Krais A, Cuenin C, Cros MP, Zaridze D, et al. Aberrant DNA methylation links cancer susceptibility locus 15q25.1 to apoptotic regulation and lung cancer. Cancer Res 2010; 70:2779-88;PMID:20332232; http://dx.doi.org/10.1158/0008-5472.CAN-09-4550.
27. Jung AY, Poole EM, Bigler J, Whitton J, Potter JD, Ulrich CM. DNA methyltransferase and alcohol dehydrogenase: gene-nutrient interactions in relation to risk of colorectal polyps. Cancer Epidemiol Biomarkers Prev 2008; 17:330-8;PMID:18268116; http://dx.doi.org/10.1158/1055-9965.EPI-07-2608.
28. Hiranuma C, Kawakami K, Oyama K, Ota N, Omura K, Watanabe G. Hypermethylation of the MYOD1 gene is a novel prognostic factor in patients with colorectal cancer. Int J Mol Med 2004; 13:413-7;PMID:14767572.
29. Xu XL, Yu J, Zhang HY, Sun MH, Gu J, Du X, et al. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. World J Gastroenterol 2004; 10:3441-54;PMID:15526363.
30. Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet 2006; 7:21-33;PMID:16369569; http://dx.doi.org/10.1038/nrg1748.
31. Vaissière T, Hung RJ, Zaridze D, Moukeria A, Cuenin C, Fasolo V, et al. Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res 2009; 69:243-52;PMID:19118009; http://dx.doi.org/10.1158/0008-5472.CAN-08-2489.
32. Sarter B, Long TI, Tsong WH, Koh WP, Yu MC, Laird PW. Sex differential in methylation patterns of selected genes in Singapore Chinese. Hum Genet 2005; 117:402-3;PMID:15928902; http://dx.doi.org/10.1007/s00439-005-1317-9.
33. Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M, et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet 2006; 38:1378-85;PMID:17072317; http://dx.doi.org/10.1038/ng1909.
34. Maekita T, Nakazawa K, Mihara M, Nakajima T, Yanaoka K, Iguchi M, et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 2006; 12:989-95;PMID:16467114; http://dx.doi.org/10.1158/1078-0432.CCR-05-2096.
35. Kirsch-Volders M, Bonassi S, Herceg Z, Hirvonen A, Möller L, Phillips DH. Gender-related differences in response to mutagens and carcinogens. Mutagenesis 2010; 25:213-21;PMID:20194421; http://dx.doi.org/10.1093/mutage/geq008.
36. Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, Willett WC. Alcohol, low-methionine-low-folate diets and risk of colon cancer in men. J Natl Cancer Inst 1995; 87:265-73;PMID:7707417; http://dx.doi.org/10.1093/jnci/87.4.265.
37. Herceg Z. Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors. Mutagenesis 2007; 22:91-103;PMID:17284773; http://dx.doi.org/10.1093/mutage/gel068.
38. van Engeland M, Weijenberg MP, Roemen GM, Brink M, de Bruïne AP, Goldbohm RA, et al. Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer. Cancer Res 2003; 63:3133-7;PMID:12810640.
39. Sharma R, Panda NK, Khullar M. Hypermethylation of carcinogen metabolism genes, CYP1A1, CYP2A13 and GSTM1 genes in head and neck cancer. Oral Dis 2010; http://dx.doi.org/10.1111/j.1601-0825.2010.01676.x.
40. Guzman LM, Koriyama C, Akiba S, Eizuru Y, Castillo D, Corvalan A, et al. High frequency of p16 promoter methylation in non-small cell lung carcinomas from Chile. Biol Res 2007; 40:365-72;PMID:18449464; http://dx.doi.org/10.4067/S0716-97602007000400011.
41. Kim DH, Nelson HH, Wiencke JK, Zheng S, Christiani DC, Wain JC, et al. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res 2001; 61:3419-24;PMID:11309302.
42. Yoshino M, Suzuki M, Tian L, Moriya Y, Hoshino H, Okamoto T, et al. Promoter hypermethylation of the p16 and Wif-1 genes as an independent prognostic marker in stage IA non-small cell lung cancers. Int J Oncol 2009; 35:1201-9;PMID:19787276.
43. Szymańska K, Levi JE, Menezes A, Wünsch-Filho V, Eluf-Neto J, Koifman S, et al. Tp53 and EGFR mutations in combination with lifestyle risk factors in tumours of the upper aerodigestive tract from South America. Carcinogenesis 2010; 31:1054-1059;PMID:19955396; http://dx.doi.org/10.1093/carcin/bgp212.